These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22801642)

  • 1. Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors.
    Uno M; Koma Y; Ban HS; Nakamura H
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5169-73. PubMed ID: 22801642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-[4-(N-Benzylamino)phenyl]-3-phenylurea derivatives as a new class of hypoxia-inducible factor-1alpha inhibitors.
    Uno M; Ban HS; Nakamura H
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3166-9. PubMed ID: 19435661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: Virtual screening, synthesis and biological evaluation.
    Chen Y; Wen D; Huang Z; Huang M; Luo Y; Liu B; Lu H; Wu Y; Peng Y; Zhang J
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6867-70. PubMed ID: 23044371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1alpha inhibitors.
    Shimizu K; Maruyama M; Yasui Y; Minegishi H; Ban HS; Nakamura H
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1453-6. PubMed ID: 20083404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.
    Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
    J Med Chem; 2005 May; 48(10):3654-8. PubMed ID: 15887974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
    Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
    Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
    Su L; Fang H; Yang K; Xu Y; Xu W
    Bioorg Med Chem; 2011 Jan; 19(2):900-6. PubMed ID: 21194957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of potent and selective 4-aminothienopyridines as B-Raf kinase inhibitors.
    Tang J; Lackey KE; Dickerson SH
    Bioorg Med Chem Lett; 2013 Jan; 23(1):66-70. PubMed ID: 23218715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule.
    Kwon HS; Kim DR; Yang EG; Park YK; Ahn HC; Min SJ; Ahn DR
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5249-52. PubMed ID: 22789427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.
    Qiao Z; Wang W; Wang L; Wen D; Zhao Y; Wang Q; Meng Q; Chen G; Wu Y; Zhou H
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6389-92. PubMed ID: 21930380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.
    Berta MA; Mazure N; Hattab M; Pouysségur J; Brahimi-Horn MC
    Biochem Biophys Res Commun; 2007 Aug; 360(3):646-52. PubMed ID: 17610843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.
    Yang L; Jiang Y; Wu SF; Zhou MY; Wu YL; Chen GQ
    Carcinogenesis; 2008 Feb; 29(2):291-8. PubMed ID: 18024476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors.
    Xu Y; Li J; Zuo Y; Deng J; Wang LS; Chen GQ
    Cancer Lett; 2011 Oct; 309(1):78-84. PubMed ID: 21669491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Phenyl-N'-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: role of omega-hydroxyl group in the covalent binding to beta-tubulin.
    Fortin S; Moreau E; Patenaude A; Desjardins M; Lacroix J; Rousseau JL; C-Gaudreault R
    Bioorg Med Chem; 2007 Feb; 15(3):1430-8. PubMed ID: 17118664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vialinin A is a ubiquitin-specific peptidase inhibitor.
    Okada K; Ye YQ; Taniguchi K; Yoshida A; Akiyama T; Yoshioka Y; Onose J; Koshino H; Takahashi S; Yajima A; Abe N; Yajima S
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4328-31. PubMed ID: 23791076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SENP1 inhibitors through in silico screening and rational drug design.
    Zhao Y; Wang Z; Zhang J; Zhou H
    Eur J Med Chem; 2016 Oct; 122():178-184. PubMed ID: 27344494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.
    Tsuzuki T; Okada H; Cho H; Tsuji S; Nishigaki A; Yasuda K; Kanzaki H
    Hum Reprod; 2012 Feb; 27(2):523-30. PubMed ID: 22128293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel competitive class of α-glucosidase inhibitors: (E)-1-phenyl-3-(4-styrylphenyl)urea derivatives.
    Kim JY; Lee JW; Kim YS; Lee Y; Ryu YB; Kim S; Ryu HW; Curtis-Long MJ; Lee KW; Lee WS; Park KH
    Chembiochem; 2010 Oct; 11(15):2125-31. PubMed ID: 20827790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a Class of Potent and Selective Non-competitive Sentrin-Specific Protease 1 Inhibitors.
    Lindenmann U; Brand M; Gall F; Frasson D; Hunziker L; Kroslakova I; Sievers M; Riedl R
    ChemMedChem; 2020 Apr; 15(8):675-679. PubMed ID: 32083799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.